U.S. health regulators, primarily at the FDA, are encountering significant difficulties in meeting mandated deadlines for medical devices and tobacco products due to the layoffs initiated by the Trump administration. Two FDA scientists reported being assigned nearly double the workload, forcing them to put aside critical oversight tasks and pre-submission feedback responsibilities. The Center for Tobacco Products has even halted new applications while focusing on urgent existing reviews, raising concerns about compliance with legal timeframes and endangering public safety.
Some U.S. health regulators are struggling to meet deadlines for reviewing medical devices and tobacco products due to layoffs from the Trump administration.
Scientists at the FDA reported a surge in workload, with instructions to prioritize existing submissions over new applications.
Collection
[
|
...
]